Orchard Therapeutics Announced Pricing of Public Offering
BOSTON and LONDON, June 05, 2019 (GLOBE NEWSWIRE) -- Orchard Therapeutics (Nasdaq: ORTX), a leading commercial-stage biopharmaceutical company dedicated to transforming the lives of patients with serious and life-threatening rare diseases through …